Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Trial Profile

Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Embolism and thrombosis; Haemorrhage; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RE-LY
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 18 May 2022 Results an analysis assessing cost-effectiveness of dabigatran compared to acenocoumarol, rivaroxaban and apixaban for thromboembolic events prevention in atrial fibrillation patients using clinical data from this trial and from a NMA published by Lopez-Lopez et al presented at the 27th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
    • 25 Aug 2021 Results assessing Plasmode Simulation of Covariate Misclassification and Transportability from individual-level data from the Randomized Evaluation of Long-Term Anticoagulation (RE-and target population of warfarin initiators in a 20% random sample of Medicare participants LY) trial presented at the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
    • 20 Mar 2021 Results (n=18113) assessing patients at risk for cardiovascular events according to their pharmacological treatment intensity and adherence, published in the American Journal of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top